High cholesterol causes: Difference between revisions
(26 intermediate revisions by 2 users not shown) | |||
Line 4: | Line 4: | ||
==Overview== | ==Overview== | ||
Elevated cholesterol level can be caused by a wide variety of factors which include: genetic (e.g. [[familial hypercholesterolemia]]); endocrine (e.g. [[diabetes mellitus]] ); drug side effect (e.g. [[beta blockers]], [[thiazide diuretics]]); kidney disease (e.g. [[nephrotic syndrome]], [[chronic kidney disease]]), and many other factors. | |||
==Causes== | ==Causes== | ||
===Life Threatening Causes=== | |||
Life-threatening causes include conditions which may result in death or permanent disability within 24 hours if left untreated. High cholesterol in itself is not a life threatening condition. | |||
===Common Causes=== | ===Common Causes=== | ||
{{ | *[[Beta blockers]]<ref name="pmid7992988">{{cite journal| author=Kasiske BL, Ma JZ, Kalil RS, Louis TA| title=Effects of antihypertensive therapy on serum lipids. | journal=Ann Intern Med | year= 1995 | volume= 122 | issue= 2 | pages= 133-41 | pmid=7992988 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=7992988 }} </ref> | ||
*[[Binge eating disorder]] | |||
*[[ | *[[Corticosteroids]]<ref name="pmid12922956">{{cite journal| author=Boers M, Nurmohamed MT, Doelman CJ, Lard LR, Verhoeven AC, Voskuyl AE et al.| title=Influence of glucocorticoids and disease activity on total and high density lipoprotein cholesterol in patients with rheumatoid arthritis. | journal=Ann Rheum Dis | year= 2003 | volume= 62 | issue= 9 | pages= 842-5 | pmid=12922956 | doi= | pmc=PMC1754645 | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=12922956 }} </ref> | ||
*[[ | |||
*[[Diabetes mellitus]] | *[[Diabetes mellitus]] | ||
*[[Estrogens]] | *[[Estrogens]] | ||
*[[Familial hypercholesterolemia]]<ref name="pmid1534286">{{cite journal| author=Genest JJ, Martin-Munley SS, McNamara JR, Ordovas JM, Jenner J, Myers RH et al.| title=Familial lipoprotein disorders in patients with premature coronary artery disease. | journal=Circulation | year= 1992 | volume= 85 | issue= 6 | pages= 2025-33 | pmid=1534286 | doi= | pmc= | url=http://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=1534286 }} </ref> | |||
*[[Familial | |||
*[[Hypothyroidism]] | *[[Hypothyroidism]] | ||
*[[ | *[[Metabolic syndrome]] | ||
*[[Nephrotic syndrome]] | *[[Nephrotic syndrome]] | ||
*[[Obesity]] | *[[Obesity]] | ||
*[[Pregnancy]] | *[[Pregnancy]] | ||
*[[Thiazide diuretics]] | |||
*[[Thiazide diuretics ]] | |||
===Causes by Organ System=== | ===Causes by Organ System=== | ||
Line 77: | Line 44: | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Drug Side Effect''' | | '''Drug Side Effect''' | ||
|bgcolor="Beige"| [[ | |bgcolor="Beige"| [[Estrogens]], [[everolimus]], [[olanzapine]], [[sirolimus]], [[temsirolimus]], [[thiazide diuretics ]], [[tofacitinib]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
Line 85: | Line 52: | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Endocrine''' | | '''Endocrine''' | ||
|bgcolor="Beige"| [[Diabetes mellitus]], [[ | |bgcolor="Beige"| [[Diabetes mellitus]], [[hypothyroidism]], [[metabolic syndrome]], [[polycystic ovary syndrome]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
Line 97: | Line 64: | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Genetic''' | | '''Genetic''' | ||
|bgcolor="Beige"| [[Analbuminaemia | |bgcolor="Beige"| [[Analbuminaemia]], [[apolipoprotein B deficiency]], [[Apolipoprotein C2|Apolipoprotein C2 deficiency]], [[Apoliprotein E|apoliprotein E deficiency]], [[Familial hypercholesterolemia|autosomal recessive hypercholesterolemia]], [[familial combined hyperlipidemia]], [[familial hypercholesterolemia]], [[Hyperlipoproteinemia|familial hyperlipoproteinemia type 5]], [[glycogen storage disease type 1a]], [[glycogenosis type 3]], [[glycogenosis type 6]], [[lecithin cholesterol acyltransferase deficiency]], [[lipoprotein lipase deficiency]], [[Niemann-Pick disease type B]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Hematologic''' | | '''Hematologic''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"| [[Zieve's syndrome]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
Line 117: | Line 84: | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Neurologic''' | | '''Neurologic''' | ||
|bgcolor="Beige"| | |bgcolor="Beige"| [[Apoliprotein E|Apoliprotein E deficiency]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Nutritional/Metabolic''' | | '''Nutritional/Metabolic''' | ||
|bgcolor="Beige"|[[ | |bgcolor="Beige"| [[Analbuminaemia]], [[Berardinelli–Seip syndrome]], [[diabetes mellitus]], [[glycogenosis type 3]], [[glycogenosis type 6]], [[metabolic syndrome]], [[ Niemann-Pick disease type B]], [[obesity]], [[Zieve's syndrome]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
Line 153: | Line 120: | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
| '''Rheumatology/Immunology/Allergy''' | | '''Rheumatology/Immunology/Allergy''' | ||
|bgcolor="Beige"| [[ | |bgcolor="Beige"| [[Hashimoto's thyroiditis ]] | ||
|- | |- | ||
|-bgcolor="LightSteelBlue" | |-bgcolor="LightSteelBlue" | ||
Line 176: | Line 143: | ||
{{col-begin|width=80%}} | {{col-begin|width=80%}} | ||
{{col-break|width=33%}} | {{col-break|width=33%}} | ||
*[[Alagille syndrome]] | *[[Alagille syndrome]] | ||
*[[Alström syndrome]] | *[[Alström syndrome]] | ||
Line 190: | Line 156: | ||
*[[Chronic kidney disease]] | *[[Chronic kidney disease]] | ||
*[[Corticosteroids]] | *[[Corticosteroids]] | ||
*[[ | *[[Diabetes mellitus]] | ||
{{col-break|width=33%}} | {{col-break|width=33%}} | ||
*[[Estrogens]] | *[[Estrogens]] | ||
*[[Everolimus]] | *[[Everolimus]] | ||
*[[Familial combined hyperlipidemia]] | *[[Familial combined hyperlipidemia]] | ||
*[[Familial hypercholesterolemia]] | *[[Familial hypercholesterolemia]] | ||
*[[Hyperlipoproteinemia|Familial hyperlipoproteinemia type 5]] | |||
*[[Glycogen storage disease type 1a]] | *[[Glycogen storage disease type 1a]] | ||
*[[Glycogenosis type 3]] | *[[Glycogenosis type 3]] | ||
*[[Glycogenosis type 6]] | *[[Glycogenosis type 6]] | ||
*[[Hypothyroidism]] | *[[Hypothyroidism]] | ||
*[[Hypothyroidism]] | *[[Hypothyroidism]] | ||
*[[Hashimoto's thyroiditis ]] | *[[Hashimoto's thyroiditis]] | ||
*[[Obesity|Lack of physical | *[[Obesity|Lack of physical activity]] | ||
*[[Lecithin cholesterol acyltransferase deficiency]] | *[[Lecithin cholesterol acyltransferase deficiency]] | ||
*[[Lipoprotein lipase deficiency]] | |||
{{col-break|width=33%}} | {{col-break|width=33%}} | ||
*[[Metabolic syndrome]] | |||
*[[Metabolic syndrome ]] | |||
*[[Nephrotic syndrome]] | *[[Nephrotic syndrome]] | ||
*[[Niemann-Pick disease type B ]] | *[[Niemann-Pick disease type B ]] | ||
Line 218: | Line 183: | ||
*[[Sirolimus]] | *[[Sirolimus]] | ||
*[[Temsirolimus]] | *[[Temsirolimus]] | ||
*[[Thiazide diuretics ]] | *[[Thiazide diuretics]] | ||
*[[Tofacitinib]] | *[[Tofacitinib]] | ||
*[[Zieve's syndrome]] | *[[Zieve's syndrome]] | ||
Line 233: | Line 198: | ||
[[Category:Cardiology]] | [[Category:Cardiology]] | ||
[[Category:Lipoproteins]] | [[Category:Lipoproteins]] | ||
[[Category:Up-To-Date]] | |||
{{WikiDoc Help Menu}} | {{WikiDoc Help Menu}} | ||
{{WikiDoc Sources}} | {{WikiDoc Sources}} |
Latest revision as of 15:44, 25 September 2013
Cholesterol Microchapters |
Clinical Correlation |
---|
Treatment |
Case Studies |
High cholesterol causes On the Web |
American Roentgen Ray Society Images of High cholesterol causes |
Risk calculators and risk factors for High cholesterol causes |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Mohamed Moubarak, M.D. [2]
Overview
Elevated cholesterol level can be caused by a wide variety of factors which include: genetic (e.g. familial hypercholesterolemia); endocrine (e.g. diabetes mellitus ); drug side effect (e.g. beta blockers, thiazide diuretics); kidney disease (e.g. nephrotic syndrome, chronic kidney disease), and many other factors.
Causes
Life Threatening Causes
Life-threatening causes include conditions which may result in death or permanent disability within 24 hours if left untreated. High cholesterol in itself is not a life threatening condition.
Common Causes
- Beta blockers[1]
- Binge eating disorder
- Corticosteroids[2]
- Diabetes mellitus
- Estrogens
- Familial hypercholesterolemia[3]
- Hypothyroidism
- Metabolic syndrome
- Nephrotic syndrome
- Obesity
- Pregnancy
- Thiazide diuretics
Causes by Organ System
Causes in Alphabetical Order
References
- ↑ Kasiske BL, Ma JZ, Kalil RS, Louis TA (1995). "Effects of antihypertensive therapy on serum lipids". Ann Intern Med. 122 (2): 133–41. PMID 7992988.
- ↑ Boers M, Nurmohamed MT, Doelman CJ, Lard LR, Verhoeven AC, Voskuyl AE; et al. (2003). "Influence of glucocorticoids and disease activity on total and high density lipoprotein cholesterol in patients with rheumatoid arthritis". Ann Rheum Dis. 62 (9): 842–5. PMC 1754645. PMID 12922956.
- ↑ Genest JJ, Martin-Munley SS, McNamara JR, Ordovas JM, Jenner J, Myers RH; et al. (1992). "Familial lipoprotein disorders in patients with premature coronary artery disease". Circulation. 85 (6): 2025–33. PMID 1534286.